Comparison study among FM/BUD (Formoterol/Budesonide), SM/FP (Salmeterol/Fluticasone), SB (Salbutamol) about bronchodilating effect part and onset of relief of dyspnea.

Trial Profile

Comparison study among FM/BUD (Formoterol/Budesonide), SM/FP (Salmeterol/Fluticasone), SB (Salbutamol) about bronchodilating effect part and onset of relief of dyspnea.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Jul 2013

At a glance

  • Drugs Budesonide/formoterol (Primary) ; Salbutamol (Primary) ; Salmeterol/fluticasone propionate (Primary)
  • Indications Asthma; Bronchoconstriction
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 22 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top